Information and Communications Technology Industry in Latvia

21 Manufacture of basic pharmaceutical products and pharmaceutical preparations

BRIZ LTD

General Information
Brand name: 
BRIZ
Registration number: 
50003027371
Year of foundation: 
1991
Industry (NACE 2): 
MANUFACTURING
10 Manufacture of food products
10.8 Manufacture of other food products
10.86 Manufacture of homogenised food preparations and dietetic foo
10.89 Manufacture of other food products n.e.c.
20 Manufacture of chemicals and chemical products
20.4 Manufacture of soap and detergents, cleaning and polishing preparations, perfumes and toilet preparations
20.42 Manufacture of perfumes and toilet preparations
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2 Manufacture of pharmaceutical preparations
21.20 Manufacture of pharmaceutical preparations
WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES
46 Wholesale trade, except of motor vehicles and motorcycles
46.4 Wholesale of household goods
46.46 Wholesale of pharmaceutical goods
Number of employees: 
51 - 100
Turnover (EUR):
10 000 001 - 20 000 000
2019
10 000 001 - 20 000 000
2018
Export volume (EUR):
10 000 001 - 30 000 000
2019
10 000 001 - 30 000 000
2018
Export countries: 
Belarus
Bulgaria
Estonia
Lithuania
Certificates: 
GMP
Head of the Company
Name, surname: 
Mr Jānis Lagzdiņš
Position: 
Chairman of the Board
Contact Information
Address: 
Rasas iela 5, Rīga, LV-1057, Latvia
Phone: 
+371-67256140
Fax: 
+371-67803159
E-mail: 
office [at] briz.lv
Contact persons' name, surname: 
Ms Aleksandra Kozlova
Contact persons' position: 
Operational Officer
Languages spoken : 
English
German
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

Production of pharmaceuticals, biologically active additives and food supplements, cosmetics, various medical devices, foodstuffs. Distribution and registration of medical products, biologically active additives, cosmetics and perfumery products, medical appointment products. Marketing, logistics, consignment stock services. Certification of series and release on the European market of medical products made outside the European Union. We offer stable growth, mutually beneficial terms of cooperation, a full-service package from introduction to the market and product registration, to marketing and logistics services. All products presented in our product list are of the highest quality, meeting all European-quality and GMP standards.

Cooperation interests: 

Expansion of our production network to the Nordic countries, introduction of high-quality pharmaceuticals, biologically active additives and food supplements, cosmetics to European markets, especially Sweden, Denmark, Norway and Finland. Expansion of the distribution network for our products.

RIGVIR

General Information
Registration number: 
40103763354
Year of foundation: 
2014
Industry (NACE 2): 
MANUFACTURING
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.1 Manufacture of basic pharmaceutical products
21.10 Manufacture of basic pharmaceutical products
PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES
70 Activities of head offices; management consultancy activities
70.1 Activities of head offices
70.10 Activities of head offices
70.2 Management consultancy activities
70.21 Public relations and communication activities
70.22 Business and other management consultancy activities
Number of employees: 
11 - 20
Turnover (EUR):
300 001 - 400 000
2020
400 001 - 500 000
2019
Export volume (EUR):
No data
2020
No data
2019
Export countries: 
Australia
Canada
United Kingdom
United States of America
Certificates: 
RIGVIR is registered in 4 countries (LV;GR;ARM;UZB);
Head of the Company
Name, surname: 
Mr Jurģis Auziņš - Member of the Board
Contact Information
Address: 
Teātra iela 9 - 7, Rīga, LV-1050, Latvia
E-mail: 
rigvir [at] rigvir.com
Contact persons' name, surname: 
Mr Jurģis Auziņš - Member of the Board
Languages spoken : 
English
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

RIGVIR represents group of companies that produce and develop oncolytic virotherapy medicines containing ECHO7 - Live oncolytic and oncotropic virus with immunomodulation activity for cancer treatment. Leading agent - RIGVIR - is approved for treatment of Melanoma skin cancer.

Cooperation interests: 

We are looking for partner who could facilitate development of our treatment agents both as an collaborative R&D partner or investor in order to successfully commercialise the drug globally.

PURIFIED

General Information
Registration number: 
40103747345
Year of foundation: 
2014
Industry (NACE 2): 
MANUFACTURING
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Number of employees: 
1-10
Turnover (EUR):
1 - 10 000
2019
20 001 - 30 000
2018
Export volume (EUR):
No data
2019
No data
2018
Head of the Company
Name, surname: 
Mr Mārtiņš Kārkliņš
Position: 
Member of the Board
Contact Information
Address: 
Mazcenu aleja 6A, Jaunmārupe, Mārupes nov., LV-2166, Latvia
Phone: 
+371-29101144
E-mail: 
office [at] purified.eu
Languages spoken : 
English
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

Cardiologists and scientists addressed the Pure Chocolate chocolate manufacturers with a request to combine the ideas of the cardiologists, the health formulas of the scientists and the premium Belgian dark chocolate. Became Purified! Dietary supplement in dark chocolate is a rich and delicious supplement for daily consumption.

SILV EXPO

General Information
Registration number: 
40103291194
Year of foundation: 
2010
Industry (NACE 2): 
MANUFACTURING
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Number of employees: 
1-10
Turnover (EUR):
10 001 - 20 000
2019
50 001 - 100 000
2018
Export volume (EUR):
No data
2019
No data
2018
Head of the Company
Name, surname: 
Mr Uģis Klētnieks - Member of the Board
Contact Information
Address: 
Alberta iela 12 - 2, Rīga, LV-1010, Latvia
Phone: 
+371-67686290
E-mail: 
info [at] silvexpo.lv
Languages spoken : 
English
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

The history of the pharmaceutical industry in Latvia is rich in its professional research institutions such as the Latvian Institute of Organic Synthesis, Latvian State Institute of Wood Chemistry, Latvian State Forest Research Institute and compatriots – nominee for the Nobel Prize – Wilhelm Ostwald and one of the founding fathers of stereochemistry Paul Walden, as well as with world-renowned innovative original products developed and marketed by fast-growing Latvian pharmaceutical companies: Olainfarm AS, Grindeks AS, Rīgas Farmaceitiskā fabrika AS.

The beauty, strength and wisdom of nature are the basic elements of our innovative solutions produced to improve health care and the quality of people’s lives. The unique natural resources of Latvia, cycles of changing seasons, clean pesticide-free environment, typology of forest ecosystem with vast biotic and abiotic qualities, as well as knowledge and traditions gathered throughout the centuries are the foundation of the intellectual potential of Latvian pharmaceutical industry and inspire us to develop and implement new ideas for the natural ingredient applications.

Since 2010, the company Silv EXPO has been working on transforming fresh ideas, developments and technologies into new generation products or services. The company has developed several innovative products for the treatment and prophylaxis of cardiovascular, respiratory, and chronic hepatic diseases that have successfully conquered the market of Latvia and the Baltics. Several in vitro and in vivostudies have been carried out in close cooperation with scientists, researchers and health care professionals, as well as a clinical study to find the most effective dosages and compound combinations of Latvian spruce and pine needle active substances – Polyprenol, Silbiol, Chlorophyllin. At the moment our company is working on the development of new technologies, while optimising the existing ones for the extraction of active natural substances. We’re also working on Nano-technological solutions for the inclusion of active substances into Nanosomes to result into the most effective pharmaceutical products.

To achieve smart and sustainable development as well as economic growth based on knowledge and innovation, the team of Silv EXPO works with imagination, courage and confidence.

The Company also supports Latvian athletes: pentathlon athlete Deniss Čerkovskis, and long jumpers Jānis Leitis and Lauma Grīva. There is a chance that they will become the most successful Latvian athletes who will have the honour of representing Latvia and promoting its name in the 31st Summer Olympics taking place in 2016 in Rio de Janeiro, Brazil.

As proven in practice, targeted scientific support can be crucial in compliance with the high standards of the games and support of athletes in leading a healthy lifestyle. For the new Silv EXPO product Kardiopren – an innovative preparation with a new type of pharmacological action of natural substances that improves myocardial and muscular functionality, as well as increases athlete’s tolerance towards load – the Summer Olympics will be a great chance to prove its effectiveness by improving the athletes’ performance.

The action of Silv EXPO developed Kardiopren is focused on the mobilisation of organism cell protection mechanisms by stimulating the non-interrupted formation cycle of Dolichol phosphate, and the activity of regenerative molecules (enzymes, transcription factors, receptors, etc.), stabilising cell membrane protein conformation. The main value of the Olympic Games – effort of athletes to show their best performance – fully complies with the values of Silv EXPO, the most important of which is excellence. Both aims share several common values, therefore, we are excited to see the results of our and the athletes’ cooperation in the Olympic Games this year.

LOTOS PHARMA

General Information
Registration number: 
40103638962
Year of foundation: 
2013
Industry (NACE 2): 
MANUFACTURING
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2 Manufacture of pharmaceutical preparations
21.20 Manufacture of pharmaceutical preparations
Number of employees: 
1-10
Turnover (EUR):
1 000 001 - 2 000 000
2020
1 000 001 - 2 000 000
2019
Export volume (EUR):
No data
2020
No data
2019
Head of the Company
Name, surname: 
Mr Kaspars Ivanovs - Member of the Board
Contact Information
Address: 
Pērnavas iela 1-39, Rīga, LV-1012, Latvia
Phone: 
+371-26356229
E-mail: 
gunita.krauze [at] lotos-pharma.com
Contact persons' name, surname: 
Ms Gunita Krauze - Marketing Project Manager
Languages spoken : 
English
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

Lotos Pharma is a pharmaceutical company that develops innovative pharmaceutical brand products exclusively from natural, raw materials of the highest quality, using unique production technologies based on the latest researches in the world. Lotos Pharma success is shaped by human, natural and technology symbiosis.

Every product of Lotos Pharma is developed in collaboration with the leading Baltic medical professionals, researchers and scientists in order to create products that meet the highest requirements so they are safe for everyone - both children and adults - and developed in accordance with the needs of the human body.

Cooperation interests: 

See Business profile.

RĪGAS FARMACEITISKĀ FABRIKA

General Information
Registration number: 
40003000765
Year of foundation: 
1991
Industry (NACE 2): 
MANUFACTURING
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2 Manufacture of pharmaceutical preparations
21.20 Manufacture of pharmaceutical preparations
Number of employees: 
51 - 100
Turnover (EUR):
5 000 001 - 10 000 000
2020
3 000 001 - 4 000 000
2019
Export volume (EUR):
No data
2020
No data
2019
Export countries: 
Estonia
Georgia
Lithuania
Certificates: 
EU GMP
Head of the Company
Name, surname: 
Ms Vilma Druliene - Chairman of the Board
Contact Information
Address: 
Ozolu iela 10, Rīga, LV-1005, Latvia
Phone: 
+371-67355550
Fax: 
+371-67355551
E-mail: 
rff [at] rff.lv
ginta.krumina [at] rff.lv
Contact persons' name, surname: 
Ms Ginta Krūmiņa
Languages spoken : 
English
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

Rīgas Farmaceitiskā Fabrika is a manufacturer of galenic products, soft pharmaceuticals and herbal drugs and teas.

The range of more than 140 products includes tinctures, drops, extracts, syrups, alcoholic and oil solutions of pharmaceuticals, liniments, ointments, herbal drugs and their composite mixtures.

Rīgas Farmaceitiskā Fabrika also provides contract-manufacturing services in accordance with EU GMP requirements for the following forms of products: solutions, syrups, ointments, creams, herbal teas.

Target export countries: 
Austria
Belarus
Estonia
Finland
Georgia
Germany
Lithuania
Netherlands
Norway
Sweden
Switzerland
Ukraine
Cooperation interests: 

We are looking for distributors, pharmacy chains and on-line drugstores of our products. We also provide contract-manufacturing services to EU GMP standards requirements.

PRIMEA

General Information
Registration number: 
40103252784
Year of foundation: 
2009
Industry (NACE 2): 
MANUFACTURING
10 Manufacture of food products
10.8 Manufacture of other food products
10.86 Manufacture of homogenised food preparations and dietetic foo
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.1 Manufacture of basic pharmaceutical products
WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES
46 Wholesale trade, except of motor vehicles and motorcycles
Number of employees: 
1-10
Turnover (EUR):
4 000 001 - 5 000 000
2018
2 000 001 - 3 000 000
2017
Export volume (EUR):
2 000 001 - 3 000 000
2018
1 000 001 - 2 000 000
2017
Export countries: 
Azerbaijan
Kazakhstan
other
Certificates: 
HACCP
Head of the Company
Name, surname: 
Mr Viktors Karpovs, Mr Pāvels Meļņičonoks - Members of the Board
Contact Information
Address: 
Ģertrūdes iela 7, Rīga, LV-1010, Latvia
Phone: 
+371-67533953
Fax: 
+371-67533963
E-mail: 
primea [at] primea.eu
Contact persons' name, surname: 
Mr Viktors Karpovs, Mr Pāvels Meļņičonoks - Members of the Board
Languages spoken : 
English
German
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

Latvian manufacturer of food supplements and cosmetics.

Extensive range of finished products.

We offer exclusive, complete contract-manufacturing services in capsulation, tabletting, blistering, packing and labelling.

We are innovative and flexible

Target export countries: 
Azerbaijan
Kazakhstan
Cooperation interests: 

Primea has the capacity to be a contract manufacturer for many customers in the pharmacy, health and food industries. From design to production

LMP

General Information
Registration number: 
40103046409
Year of foundation: 
1992
Industry (NACE 2): 
ELECTRICITY, GAS, STEAM AND AIR CONDITIONING SUPPLY
35 Electricity, gas, steam and air conditioning supply
35.2 Manufacture of gas; distribution of gaseous fuels through mains
MANUFACTURING
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2 Manufacture of pharmaceutical preparations
21.20 Manufacture of pharmaceutical preparations
Number of employees: 
11 - 20
Turnover (EUR):
1 000 001 - 2 000 000
2020
1 000 001 - 2 000 000
2019
Export volume (EUR):
No data
2020
No data
2019
Export countries: 
Armenia
Azerbaijan
Belarus
Czech Republic
Estonia
Georgia
Kazakhstan
Lithuania
Slovakia
Turkey
Turkmenistan
Ukraine
Uzbekistan
Certificates: 
GMP
Head of the Company
Name, surname: 
Mr Jānis Miķelsons - Chairman of the Board
Contact Information
Address: 
Vietalvas iela 1, Rīga, LV-1009, Latvia
Phone: 
+371-67040788
Fax: 
+371-67040787
E-mail: 
info [at] lmp.lv
Contact persons' name, surname: 
Mr Jānis Miķelsons - Chairman of the Board
Languages spoken : 
Ainu
English
German
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

Manufacturing of liquid and semi-solid drug dosage forms (13 different products) and 12 different products with CE marking, registered as medical devices in the EU. Development and manufacturing of new products.

Target export countries: 
Armenia
Azerbaijan
Belarus
Czech Republic
Estonia
Kazakhstan
Lithuania
Slovakia
Turkey
Turkmenistan
Ukraine
Uzbekistan
Cooperation interests: 

We are looking for partners who could organise sales and distribution of LMP products, supplying the full range of marketing services: preparation of marketing strategy; organising cooperation with medical wholesalers, drugstore chains, pharmacists, and doctors; execution of publicity activities; and production of publicity materials.

We also offer private-label manufacturing for medical devices and for medical devices and drugs

KALCEKS

General Information
Registration number: 
40003059981
Year of foundation: 
1992
Industry (NACE 2): 
MANUFACTURING
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2 Manufacture of pharmaceutical preparations
21.20 Manufacture of pharmaceutical preparations
WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES
46 Wholesale trade, except of motor vehicles and motorcycles
46.4 Wholesale of household goods
46.46 Wholesale of pharmaceutical goods
Number of employees: 
21 - 50
Turnover (EUR):
40 000 001 - 50 000 000
2018
5 000 001 - 10 000 000
2017
Export volume (EUR):
50 000 001 - ...
2018
1 000 001 - 2 000 000
2017
Certificates: 
ISO 9001, ISO 14001, GMP, GLP, OHSAS 18001
Head of the Company
Name, surname: 
Mr Juris Hmeļņickis Ph. D. - Chairman of the Board
Contact Information
Address: 
Krustpils iela 71A, Rīga, LV-1057, Latvia
Phone: 
+371-67083320
E-mail: 
kalceks [at] kalceks.lv
Contact persons' name, surname: 
Ms Sintija Zvarica
Languages spoken : 
English
Estonian
Finnish
German
Latvian
Russian
Swedish
Business Profile and Cooperation Interests
Business profile: 

Production and sales of pharmaceuticals.

Cooperation interests: 

For pharmaceutical wholesalers focusing on B2B activities, for doctors in questions of products selection strategy,  for raw material suppliers in sources for active pharmaceutical ingredients for medicines included in company’s portfolio.

Pages

Subscribe to 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations